Synthetic peptide derived from the C terminal domain of human CMYA5.
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/200 - 1/2000. Predicted molecular weight: 449 kDa.
Use at an assay dependent concentration.
Expressed in skeletal muscle; at a strong level and in heart.
Contains 1 B30.2/SPRY domain.
Contains 2 fibronectin type-III domains.
Amphipathic helix regions act as an anchoring domain for PKA, and appear to be responsible of the interaction between myospryn and PRKAR2A.
Cytoplasm. Cytoplasm > perinuclear region. Found predominantly at the periphery of the nucleus but also throughout the cell. Localized at the Z-line costamere connection level of the sarcolemma and in lysosomes.
Information by UniProt
Cardiomyopathy associated 5 antibody
Anti-CMYA5 antibody (ab75351)参考文献
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"